ACHV Q2 2024 Earnings — Achieve Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

ACHVAchieve Life Sciences, Inc.

$233M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$8M

Net Income

-$8M

EPS (Diluted)

$-0.25

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$65M

Total Liabilities

$23M

Stockholders' Equity

$42M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$8M	-$8M	-9.3%
Net Income	-$8M	-$8M	-2.7%